AU3138595A - Haloperidol analogs and the use thereof - Google Patents
Haloperidol analogs and the use thereofInfo
- Publication number
- AU3138595A AU3138595A AU31385/95A AU3138595A AU3138595A AU 3138595 A AU3138595 A AU 3138595A AU 31385/95 A AU31385/95 A AU 31385/95A AU 3138595 A AU3138595 A AU 3138595A AU 3138595 A AU3138595 A AU 3138595A
- Authority
- AU
- Australia
- Prior art keywords
- haloperidol
- analogs
- haloperidol analogs
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- LNEPOXFFQSENCJ-UHFFFAOYSA-N haloperidol Chemical class C1CC(O)(C=2C=CC(Cl)=CC=2)CCN1CCCC(=O)C1=CC=C(F)C=C1 LNEPOXFFQSENCJ-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4515—Non condensed piperidines, e.g. piperocaine having a butyrophenone group in position 1, e.g. haloperidol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US475990 | 1983-03-16 | ||
| US27787194A | 1994-07-20 | 1994-07-20 | |
| US277871 | 1994-07-20 | ||
| US47599095A | 1995-06-07 | 1995-06-07 | |
| PCT/US1995/009191 WO1996002250A1 (en) | 1994-07-20 | 1995-07-20 | Haloperidol analogs and the use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU3138595A true AU3138595A (en) | 1996-02-16 |
Family
ID=26958764
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU31385/95A Abandoned AU3138595A (en) | 1994-07-20 | 1995-07-20 | Haloperidol analogs and the use thereof |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU3138595A (en) |
| WO (1) | WO1996002250A1 (en) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19812331A1 (en) * | 1998-03-20 | 1999-09-23 | Merck Patent Gmbh | New benzo-heterocyclic substituted piperidine derivatives useful as excitatory aminoacid receptor antagonists, used e.g. for treating neurodegenerative diseases |
| US6528529B1 (en) * | 1998-03-31 | 2003-03-04 | Acadia Pharmaceuticals Inc. | Compounds with activity on muscarinic receptors |
| US6828460B2 (en) | 1999-03-22 | 2004-12-07 | Pfizer Inc. | Resorcinol derivatives |
| EP1220840A2 (en) | 1999-10-15 | 2002-07-10 | Bristol-Myers Squibb Pharma Company | Bicyclic and tricyclic amines as modulators of chemokine receptor activity |
| US6784200B2 (en) | 2000-10-13 | 2004-08-31 | Bristol-Myers Squibb Pharma Company | Bicyclic and tricyclic amines as modulators of chemokine receptor activity |
| US6476041B1 (en) | 1999-10-29 | 2002-11-05 | Merck & Co., Inc. | 1,4 substituted piperidinyl NMDA/NR2B antagonists |
| GB0007842D0 (en) * | 2000-03-31 | 2000-05-17 | Spruce Barbara | Sigma receptor ligands and their medical uses |
| EA005974B1 (en) | 2001-02-23 | 2005-08-25 | Мерк Энд Ко., Инк. | N-substituted nonaryl-heterocyclic nmda/nr2b antagonists |
| US7259157B2 (en) | 2001-04-03 | 2007-08-21 | Merck & Co., Inc. | N-substituted nonaryl-heterocyclo amidyl NMDA/NR2B Antagonists |
| PL378268A1 (en) | 2002-11-26 | 2006-03-20 | Pfizer Products Inc. | Phenyl substituted piperidine compounds for use as ppar activators |
| US7786140B2 (en) | 2003-09-25 | 2010-08-31 | Shionogi & Co., Ltd. | Piperidine derivative having NMDA receptor antagonistic activity |
| WO2006050511A2 (en) * | 2004-11-03 | 2006-05-11 | University Of North Texas Health Science Center At Fort Worth | Butyrophenomenes and sigma-1 receptor antagonists protect against oxidatives-stress |
-
1995
- 1995-07-20 AU AU31385/95A patent/AU3138595A/en not_active Abandoned
- 1995-07-20 WO PCT/US1995/009191 patent/WO1996002250A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO1996002250A1 (en) | 1996-02-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP960365B1 (en) | New medicaments and the use thereof | |
| ZA95776B (en) | Novel formulation | |
| AU2473195A (en) | Single use syringes | |
| AU1852995A (en) | Polychelants | |
| AU3138595A (en) | Haloperidol analogs and the use thereof | |
| AU4299296A (en) | Enterokinetic benzamide | |
| IL130348A0 (en) | Imidazopyridazines and medicaments containing the same | |
| AU697648B2 (en) | 2-arylpyrimidines and herbicidal use thereof | |
| GB9411045D0 (en) | Compounds and use | |
| AU3634595A (en) | Bis-oxazolidines and their use | |
| AU4344996A (en) | Vessel-puncturing cannula | |
| AU1613295A (en) | Descender | |
| ZA955128B (en) | Novel amido-quinoxalinediones the preparation and use thereof | |
| AU3982695A (en) | Oxazolyl- and thiazolylimidazo-benzo- and thienodiazepines and their use as medicaments | |
| AU691690B2 (en) | Acrolein-releasing composition and use thereof | |
| AU4018395A (en) | Compounding elements and use thereof | |
| AU1289695A (en) | Human stanniocalcin-alpha | |
| AU3838695A (en) | Use of the bio-spectrum in animal embryo-engineering | |
| AU3885995A (en) | Novel medicinal use | |
| AU3776495A (en) | Aryloxycycloalkenyl and aryloxyiminocycloalkenylhydroxyureas | |
| AU1255895A (en) | Human mutt2 | |
| GB9406479D0 (en) | Novel use | |
| GB9418759D0 (en) | Novel use | |
| AUPM580194A0 (en) | The sunglove | |
| AUPM964294A0 (en) | The wheelbed |